![Karine Lignel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karine Lignel
Grundare på
ONCODESIGN PRECISION MEDICINE
Profil
Karine Lignel is the founder of Oncodesign Precision Medicine SA, founded in 2020, holding the title of Chief Operating Officer, Director & Deputy MD.
Current jobs include Chairman at Société Financière Aquitaine De Participation, Director, Group Chief Development Officer & SVP at Oncodesign SA since 2021, and Director at SILIOS Technologies SA. Former jobs include Director at Ariana Pharmaceuticals SA, Amorçage Rhône-Alpes SAS as Investment Director, Sartorius Polyplus SAS as Director, Confederation Nationale Crédit Mutuel SA as Director, EndoControl SAS as Director, Voluntis SA as Non-Voting Director, ImmunID SAS as Director, e(ye).
Brain SA as Director, Global Bioenergies SA as Director from 2013 to 2020, Tissium SA as Director, Maat Pharma SA as Director, CM-CIC Innovation SASU as Investment Director from 2013 to 2016, Krono-Safe SA as Director, Coldway SA as Member-Supervisory Board, Rhones Alpes Creation as Member-Supervisory Board, Nanobiotix SA as Member-Supervisory Board, MedinCell SA as Member-Supervisory Board, and ForCity SAS as Member-Supervisory Board.
Education includes an MBA from ESSEC Business School and undergraduate studies at Ecole Superieure des Industries Agricoles et Alimentaires.
Aktiva positioner av Karine Lignel
| Företag | Position | Start |
|---|---|---|
| ONCODESIGN | Direktör/Styrelseledamot | 2008-05-14 |
| ONCODESIGN PRECISION MEDICINE | Grundare | 2020-12-15 |
Société Financière Aquitaine De Participation
 Société Financière Aquitaine De Participation Financial ConglomeratesFinance Functions as an investment holding company | Ordförande | - |
SILIOS Technologies SA
 SILIOS Technologies SA Electronic ComponentsElectronic Technology Manufactures optical miniature parts | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Karine Lignel
| Företag | Position | Slut |
|---|---|---|
| GLOBAL BIOENERGIES SA | Direktör/Styrelseledamot | 2020-03-01 |
CM-CIC Innovation SASU
 CM-CIC Innovation SASU Investment ManagersFinance CM-CIC Innovation invests in companies located in France. The firm targets companies operating in deeptech, software & IT and health sectors. It provides financing for early stage transactions, It acts as a lead investor. | Privat kapitalinvesterare | 2016-03-01 |
Ariana Pharmaceuticals SA
 Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Provides pharmaceutical, clinical and data technology | Direktör/Styrelseledamot | - |
| NANOBIOTIX | Direktör/Styrelseledamot | - |
| VOLUNTIS S.A. | Direktör/Styrelseledamot | - |
Karine Lignels utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
35
Första gradens relationer
24
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 24 |
|---|---|
Ariana Pharmaceuticals SA
Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Provides pharmaceutical, clinical and data technology | Health Technology |
ESSEC Business School
 ESSEC Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CM-CIC Innovation SASU
CM-CIC Innovation SASU Investment ManagersFinance CM-CIC Innovation invests in companies located in France. The firm targets companies operating in deeptech, software & IT and health sectors. It provides financing for early stage transactions, It acts as a lead investor. | Finance |
Amorçage Rhône-Alpes SAS
 Amorçage Rhône-Alpes SAS Investment ManagersFinance ARA is an active manager which invests in innovative French technology companies with high growth potential in a range of sectors including biotechnology, information technology and telecom, medical technology, nanotechnology and environment. The firm seeks to invest EUR 50,000-200,000 in companies which are either in their creation stage or have been in operation for less than two years, which are based in the administrative territory of the Rhone-Alpes region and which have technology originating from, or being developed in cooperation with a French public research institution. ARA usually co-invests with other financing partners and typically expects to exit their investments after three to seven years. The firm's investment committee makes the investment decisions. | Finance |
Coldway SA
 Coldway SA Wholesale DistributorsDistribution Services Manufactures refrigerated and insulated containers | Distribution Services |
Oncodesign SA
 Oncodesign SA BiotechnologyHealth Technology Develops preclinical evaluation of novel anticancer therapies | Health Technology |
Polyplus-transfection SA
 Polyplus-transfection SA BiotechnologyHealth Technology Provides cell and gene therapy services | Health Technology |
Confederation Nationale Crédit Mutuel SA
 Confederation Nationale Crédit Mutuel SA Major BanksFinance Provides national banking services | Finance |
Rhones Alpes Creation | |
EndoControl SAS
 EndoControl SAS Medical SpecialtiesHealth Technology Designs, develops and markets robotics solutions for laparoscopic surgeries | Health Technology |
Nanobiotix SA
 Nanobiotix SA Pharmaceuticals: MajorHealth Technology Develops and manufactures nanotherapeutics for treatment of cancer | Health Technology |
Ecole Superieure des Industries Agricoles et Alimentaires
 Ecole Superieure des Industries Agricoles et Alimentaires Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voluntis SA
 Voluntis SA Packaged SoftwareTechnology Services Develops anti-cancer treatment platform | Technology Services |
SILIOS Technologies SA
SILIOS Technologies SA Electronic ComponentsElectronic Technology Manufactures optical miniature parts | Electronic Technology |
ImmunID SAS
 ImmunID SAS Medical SpecialtiesHealth Technology Researches and develops diagnostic tools for monitoring immune cell repertoire | Health Technology |
e(ye) Brain SA
 e(ye) Brain SA Medical DistributorsDistribution Services Provides medical research services | Distribution Services |
Global Bioenergies SA
 Global Bioenergies SA Chemicals: SpecialtyProcess Industries Develops industrial processes to convert renewable sources into hydrocarbons through fermentation | Process Industries |
MedinCell SA
 MedinCell SA Pharmaceuticals: MajorHealth Technology Provides therapeutic solutions | Health Technology |
Krono-Safe SA
 Krono-Safe SA Packaged SoftwareTechnology Services Provides software solutions for the development of embedded systems | Technology Services |
Tissium SA
 Tissium SA BiotechnologyHealth Technology Develops biomorphic and programmable polymers for tissue reconstruction | Health Technology |
Maat Pharma SA
 Maat Pharma SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company which develops and commercializes patient-microbiome symbiosis to improve survival outcomes in oncology | Health Technology |
ForCity SAS
 ForCity SAS Miscellaneous Commercial ServicesCommercial Services Provides support services to the decision for the actors public and economic territories | Commercial Services |
Société Financière Aquitaine De Participation
Société Financière Aquitaine De Participation Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Oncodesign Precision Medicine SA
 Oncodesign Precision Medicine SA Pharmaceuticals: MajorHealth Technology Discovers and develops new molecules for the health treatments in oncology | Health Technology |
